Canada Considers Extending Readiness Inspections To Non-COVID-19 Trials

Health Canada’s early inspection program helps sponsors of COVID-19 clinical trials better identify gaps in their procedures before enrolling patients. It also provides intelligence on sites that may need to undergo a full GCP inspection later. 

PS1805_Test Medicine_579176380_1200.jpg
Compliance Readiness Inspections Are Conducted Earlier In The Lifecycle Of A Trial • Source: Shutterstock

A new type of inspection introduced by Health Canada to ensure regulatory compliance for clinical trials of drugs, vaccines and medical devices for COVID-19 has drawn positive feedback and could potentially be used for other types of studies.

Compliance readiness inspections (CRIs) were rolled out in October 2020 to streamline the conduct of COVID-19 trials and they have...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D